Patent Expiry
AQST: ZUPLENZ: recorded patent 9095577 expiry
July 13, 2030 · ONDANSETRON. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- July 13, 2030
- Company
- Aquestive Therapeutics, Inc. (AQST)
- Drug
- ONDANSETRON
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
ZUPLENZ: recorded patent 9095577 expiry
Orange Book application NDA022524, product 001, listed patent 9095577 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source